158 related articles for article (PubMed ID: 9567701)
1. [Interactions between physicians and drug industry. Between Skylla and Kharybdis].
Kristiansen IS
Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1228-33. PubMed ID: 9567701
[No Abstract] [Full Text] [Related]
2. [Drug industry--physicians--society].
Slettevold L
Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1242-3. PubMed ID: 9567703
[No Abstract] [Full Text] [Related]
3. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
Rapp MS; Woollard R
CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
[No Abstract] [Full Text] [Related]
4. Student rally. Med school attendees write ethics code on drug firms.
Romano M
Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
[No Abstract] [Full Text] [Related]
5. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
[No Abstract] [Full Text] [Related]
6. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Schetky DH
Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
[TBL] [Abstract][Full Text] [Related]
7. Drug rep advice raises gift ethics concerns.
Greene J
Minn Med; 2001 Jan; 84(1):22-3. PubMed ID: 11202522
[No Abstract] [Full Text] [Related]
8. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
9. What market values are doing to medicine.
Relman AS
Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349
[No Abstract] [Full Text] [Related]
10. Ethical boundaries between the medical profession and the health care industry.
Ravindran J
Med J Malaysia; 2000 Aug; 55 Suppl B():43-50. PubMed ID: 11125521
[No Abstract] [Full Text] [Related]
11. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
12. The dermatology-industry interface: defining the boundaries.
Sams WM; Freedberg IM
J Am Acad Dermatol; 2000 Sep; 43(3):550-4. PubMed ID: 10954674
[TBL] [Abstract][Full Text] [Related]
13. [Physicians and drug industry: attitudes and practice].
Aasland OG; Førde R
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
[TBL] [Abstract][Full Text] [Related]
14. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?].
Eckardt VF
Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695
[No Abstract] [Full Text] [Related]
15. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Castresana L; Mejia R; Aznar M
Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
[TBL] [Abstract][Full Text] [Related]
16. Big pharma and American psychiatry.
Sharfstein SS
J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
[No Abstract] [Full Text] [Related]
17. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
18. [Do you have anything to hide?].
Nylenna M
Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1171. PubMed ID: 9567687
[No Abstract] [Full Text] [Related]
19. Drug marketing practices criticized.
Wagner L
Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
[No Abstract] [Full Text] [Related]
20. Physicians and pharma--an unholy alliance?
Borders JM
J Ky Med Assoc; 2007 Apr; 105(4):177-8. PubMed ID: 17494281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
